Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
40)33-31(37)22-9-11-27-28(19-22)36-20-24(32(34)38)17-23-18-25(41-3)10-12-26(23)30(36)29(27)21-7-5-4-6-8-21
This pathway appears to account for a major portion of methionine oxidation in vitro
15aR)-3-Benzyl-6
Lys05 treatment results in a 53% reduction in the average daily tumor growth rate compared with vehicle-treated controls
MK-0608 26075 40)33-31(37)22-9-11-27-28(19-22)36-20-24(32(34)38)17-23-18-25(41-3)10-12-26(23)30(36)29(27)21-7-5-4-6-8-21MK 0608 is a potent and orally bioavailable inhibitor of HCV replication in vitro with an EC50 of 0. 3 M (EC90=1. 3 M) in the subgenomic replicon assay. Product information CAS Number: 443642 29 3 Molecular Weight: 280. 28 Formula: C12H16N4O4 Chemical Name: (2R,3R,4R,5R) 2 {4 amino 7H pyrrolo[2,3 d]pyrimidin 7 yl} 5 (hydroxymethyl) 3 methyloxolane 3,4 diol Smiles: C[C@]1(O)[C@@H](O[C@H](CO)[C@H]1O)N1C=CC2=C(N)N=CN=C12 InChiKey: IRZRJANZDIOOIF
US$ 2756.25
US$ 9100.00
US$ 5001.15
US$ 2835.00
US$ 8840.00
US$ 9602.25
US$ 9146.80
US$ 5457.90
US$ 6247.50
US$ 4553.12
US$ 6247.50